Annual SGA
$136.46 M
+$16.29 M+13.56%
December 31, 2023
Summary
- As of February 10, 2025, DCPH annual SGA is $136.46 million, with the most recent change of +$16.29 million (+13.56%) on December 31, 2023.
- During the last 3 years, DCPH annual SGA has risen by +$22.38 million (+19.61%).
Performance
DCPH SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly SGA
$33.92 M
-$5.22 M-13.34%
March 1, 2024
Summary
- As of February 10, 2025, DCPH quarterly SGA is $33.92 million, with the most recent change of -$5.22 million (-13.34%) on March 1, 2024.
- Over the past year, DCPH quarterly SGA has increased by +$672.00 thousand (+2.02%).
Performance
DCPH Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
-$5.61 B
-$190.42 M-3.51%
March 1, 2024
Summary
- As of February 10, 2025, DCPH TTM SGA is -$5.61 billion, with the most recent change of -$190.42 million (-3.51%) on March 1, 2024.
- Over the past year, DCPH TTM SGA has dropped by -$5.74 billion (-4435.20%).
Performance
DCPH TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
DCPH Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.6% | +2.0% | -4435.2% |
| 3 y3 years | +19.6% | +2.0% | -4435.2% |
| 5 y5 years | +543.3% | +2.0% | -4435.2% |
DCPH Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -11.9% | -13.3% | -16.5% | +50.8% | at low |
| 5 y | 5-year | at high | -50.1% | -13.3% | -30.0% | +247.3% | at low |
| alltime | all time | at high | -96.2% | -13.3% | -96.0% | +3756.4% | at low |
Deciphera Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $33.92 M(-13.3%) | $138.93 M(+1.8%) |
| Dec 2023 | $136.46 M(+13.6%) | $39.15 M(+17.7%) | $136.46 M(+5.4%) |
| Sep 2023 | - | $33.25 M(+2.0%) | $129.51 M(+2.6%) |
| Jun 2023 | - | $32.61 M(+3.7%) | $126.28 M(+2.4%) |
| Mar 2023 | - | $31.45 M(-2.3%) | $123.30 M(+2.6%) |
| Dec 2022 | $120.17 M(-11.8%) | $32.20 M(+7.2%) | $120.17 M(-4.0%) |
| Sep 2022 | - | $30.03 M(+1.4%) | $125.12 M(-4.2%) |
| Jun 2022 | - | $29.63 M(+4.6%) | $130.62 M(-2.4%) |
| Mar 2022 | - | $28.32 M(-23.8%) | $133.83 M(-1.8%) |
| Dec 2021 | $136.25 M(+19.4%) | $37.15 M(+4.6%) | $136.25 M(+5.5%) |
| Sep 2021 | - | $35.53 M(+8.2%) | $129.17 M(+4.3%) |
| Jun 2021 | - | $32.83 M(+6.8%) | $123.79 M(+2.4%) |
| Mar 2021 | - | $30.75 M(+2.3%) | $120.89 M(+6.0%) |
| Dec 2020 | $114.08 M | $30.07 M(-0.2%) | $114.08 M(+5.9%) |
| Sep 2020 | - | $30.14 M(+0.7%) | $107.75 M(+12.7%) |
| Jun 2020 | - | $29.93 M(+25.1%) | $95.58 M(+21.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $23.94 M(+0.8%) | $78.82 M(+15.7%) |
| Dec 2019 | $68.12 M(+221.1%) | $23.74 M(+32.0%) | $68.12 M(+33.9%) |
| Sep 2019 | - | $17.98 M(+36.6%) | $50.85 M(+33.4%) |
| Jun 2019 | - | $13.16 M(-0.5%) | $38.13 M(+29.6%) |
| Mar 2019 | - | $13.24 M(+104.4%) | $29.42 M(+38.7%) |
| Dec 2018 | $21.21 M(+85.7%) | $6.47 M(+23.1%) | $21.21 M(+9.2%) |
| Sep 2018 | - | $5.26 M(+18.1%) | $19.42 M(+17.1%) |
| Jun 2018 | - | $4.45 M(-11.4%) | $16.59 M(+15.4%) |
| Mar 2018 | - | $5.03 M(+7.4%) | $14.38 M(+25.9%) |
| Dec 2017 | $11.42 M(+101.3%) | $4.68 M(+92.6%) | $11.42 M(+30.7%) |
| Sep 2017 | - | $2.43 M(+8.3%) | $8.74 M(+14.1%) |
| Jun 2017 | - | $2.24 M(+8.6%) | $7.66 M(+41.4%) |
| Mar 2017 | - | $2.07 M(+3.5%) | $5.41 M(+61.8%) |
| Dec 2016 | $5.67 M(+10.5%) | $2.00 M(+47.9%) | $3.35 M(+147.9%) |
| Sep 2016 | - | $1.35 M | $1.35 M |
| Dec 2015 | $5.13 M | - | - |
FAQ
- What is Deciphera Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals annual SGA year-on-year change?
- What is Deciphera Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals quarterly SGA year-on-year change?
- What is Deciphera Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals TTM SGA year-on-year change?
What is Deciphera Pharmaceuticals annual SGA?
The current annual SGA of DCPH is $136.46 M
What is the all time high annual SGA for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high annual SGA is $136.46 M
What is Deciphera Pharmaceuticals annual SGA year-on-year change?
Over the past year, DCPH annual SGA has changed by +$16.29 M (+13.56%)
What is Deciphera Pharmaceuticals quarterly SGA?
The current quarterly SGA of DCPH is $33.92 M
What is the all time high quarterly SGA for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high quarterly SGA is $39.15 M
What is Deciphera Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, DCPH quarterly SGA has changed by +$672.00 K (+2.02%)
What is Deciphera Pharmaceuticals TTM SGA?
The current TTM SGA of DCPH is -$5.61 B
What is the all time high TTM SGA for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high TTM SGA is -$145.59 M
What is Deciphera Pharmaceuticals TTM SGA year-on-year change?
Over the past year, DCPH TTM SGA has changed by -$5.74 B (-4435.20%)